# Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation

> **NCT06945614** · PHASE1 · RECRUITING · sponsor: **General Biophysics LLC** · enrollment: 16 (estimated)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** Xenon gas inhalation

## Key facts

- **NCT ID:** NCT06945614
- **Lead sponsor:** General Biophysics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-16
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06945614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06945614, "Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06945614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*